why choose us

First received: November 07, 2023

Clinical Trial: Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Non-muscle Invasive Bladder Cancer

Study Type: OBSERVATIONAL


Official Title: A Randomized Cross-Over Study to Evaluate Patient Preference and Satisfaction With Urine-based Molecular Testing Versus Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)

Brief Summary: The purpose of this study is to evaluate patient-reported preference for urine based molecular testing (CxBladder Monitor) compared to cystoscopy for patients on surveillance for Nonmuscle Invasive Bladder Cancer (NMIBC).Urine based molecular testing involves noninvasive testing of a urine sample for biomarkers associated with disease recurrence.Cystoscopy is an examination of the bladder and urethra using a thin tube like instrument that is inserted into the urethra.

Read more